comparemela.com

Latest Breaking News On - Medivir - Page 3 : comparemela.com

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

Magnus christensenJens lindbergNasdaq stockholmSmall cap

Medivir to present at the Carlsquare Equity Research Investor Day

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

Jens lindbergMagnus christensenCarlsquare equity research investor dayNasdaq stockholmSmall capHealth care amp hospitalsMedical pharmaceuticalsNew products amp services

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

Jens lindbergMagnus christensenQuotient sciencesNasdaq stockholmSmall cap

Medivir to present at the Redeye Life Science Day

/PRNewswire/ Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

Richard ramaniusJens lindbergMagnus christensenRedeye life science dayNasdaq stockholmSmall cap

Notice of Extraordinary General Meeting in Medivir AB (publ)

/PRNewswire/ The shareholders in Medivir AB (publ) reg. no. 556238-4361 (the "Company") are hereby convened to the extraordinary general meeting, which will.

Grev turegatanUli hacksellSwedish companies registration officeSwedish companiesCompany articles of associationEuroclear swedenPrivacy policySwedish companies registrationSwedish companies actExtraordinary general

vimarsana © 2020. All Rights Reserved.